BioSpace News Archive

Drug Development

NervGen Presents Additional Phase 1 Clinical Trial Data for NVG-291 at Neuroscience 2021

Safety Review Committee Provides Recommendation to Proceed to Multiple Ascending Dose Portion of the Trial.

November 4, 2021
·
7 min read
Business

Quoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial Officer

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced that it has appointed Gordon Dunn as Quoin’s Chief Financial Officer, effective immediately.

November 4, 2021
·
3 min read
Genetown

Imara to Present Clinical and Preclinical Data at the American Society of Hematology (ASH) Annual Meeting 2021

Imara Inc. today announced that it will present clinical and preclinical data at the American Society of Hematology (ASH) Annual Meeting to be held December 11-14, 2021.

November 4, 2021
·
6 min read
Genetown

Apellis to Present New Data Reinforcing EMPAVELI™ (pegcetacoplan) Efficacy and Safety in Patients with PNH at the 2021 ASH Annual Meeting

Apellis Pharmaceuticals, Inc today announced that five abstracts were accepted for presentation at the American Society of Hematology (ASH) Annual Meeting to be held December 11-14, 2021.

November 4, 2021
·
12 min read
Drug Development

Arcellx to Present New Clinical Data from its CART-ddBCMA Phase 1 Trial in Patients with Relapsed and Refractory Multiple Myeloma at the 63rd ASH Annual Meeting and Exposition

Arcellx, Inc. today announced the presentation of new Phase 1 clinical trial data of its CART-ddBCMA for the treatment of patients with relapsed and refractory multiple myeloma.

November 4, 2021
·
1 min read
Business

IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update

IGM Biosciences, Inc. today announced its financial results for the third quarter ended September 30, 2021 and provided an update on recent developments.

November 4, 2021
·
15 min read
Biotech Beach

Adagene Unveils Preclinical Data from Two Transformative Antibody Programs at Upcoming American Society of Hematology (ASH) Annual Meeting

Adagene Inc. today announced publication of two abstracts featuring preclinical data from its expanding pipeline in advance of the 63rd ASH Annual Meeting & Exposition.

November 4, 2021
·
6 min read
Genetown

Mustang Bio Announces MB-106 CD20-Targeted CAR T Data Selected for Presentation at 63rd American Society of Hematology (ASH) Annual MeetingKey opinion leader webinar on Thursday, December 16, 2021, at 2:30 p.m. ET

Mustang Bio, Inc. today announced that interim Phase 1/2 data have been selected for a poster presentation at the 63rd American Society of Hematology Annual Meeting (“ASH2021”), which is being held from December 11-14, 2021.

November 4, 2021
·
7 min read
Genetown

EIP Pharma Announces New Data Presentations from Phase 2 Treatment Trial in Dementia with Lewy Bodies at Upcoming Scientific Conference and New Board Appointment

EIP Pharma Inc. data will be presented at the 14th Clinical Trials in Alzheimer’s Disease (CTAD) meeting that will be held in Boston November 9th through 12th, 2021.

November 4, 2021
·
3 min read
Genetown

Syndax Pharmaceuticals to Present Updated Data from SNDX-5613 and Axatilimab Clinical Programs During Oral Sessions at 63rd ASH Annual Meeting

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), today announced that updated data from both of its ongoing SNDX-5613 and axatilimab programs will be featured during oral sessions at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 11-14, 2021.

November 4, 2021
·
8 min read